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How many goodly creatures are there here!
How beauteous mankind is! 0 brave new world,
That has such people in 't!
-Miranda, The Tempest, Act V:Sc 1
For many, the phrase "brave new world" evokes images of the chilling
society envisioned by novelist Aldous Huxley in which human beings are engineered in the laboratory. But as Professor Albert Jonsen reminds us in the introduction to Reproductive Genetics and the Law, the phrase was first used by
Shakespeare in The Tempest when Miranda first sees normal human beings on
the remote island where she has been reared along with the monstrous Caliban,
the spirit Ariel, and other creatures of her father's magic art.
The authors of Reproductive Genetics and the Law, Sherman Elias and
George Annas, introduce us to a brave new world that is closer in spirit to
Shakespeare than Huxley, peopled as it is with parents, infants, and physicians
striving to be "goodly creatures" in the sense of being free from fatal genetic
defects. The decision to place the extraordinary advances that have occurred in
our understanding of human genetics in the familiar world of medicine enables
the authors to underscore the enormous potential for relief of pain and suffering
offered by recent advances in genetics without sacrificing the opportunity to
criticize aspects of the new science that could lead to abuse.
The authors announce at the beginning that their goal is to avoid the profes*Professor of Law and Professor of Community and Family Medicine, Georgetown University.
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sional bias so common in the literature: medical and scientific writers tend to
ignore social policy issues, and lawyers and ethicists tend to misunderstand or
ignore relevant scientific facts (p. xi). This fruitful, interdisciplinary collaboration of obstetrician/geneticist and health lawyer/medical ethicist more than
lives up to the goal, containing as it does concise, accurate and useful information about human genetics and relevant areas of law. The scope of the book is
remarkably ambitious, moreover, for it covers not only such matters as genetic
screening and gene therapy, but also contains a chapter on "Reproductive Liberty," one on "Treatment of Handicapped Newborns," and one on "Gene
Therapy." There is even a chapter on "Noncoital Reproduction" that discusses such new reproductive technologies as in vitro fertilization and surrogate mothers. The authors have included a judicious selection of illustrations
and photographs and chapter references that serve to guide the interested
reader to much more detailed discussions of both scientific and legal matters.
Although the emphasis is on scientific and legal facts, ethical and policy
issues are not neglected. In some of the more contentious areas, the authors
present the arguments on both (or more accurately, all) sides of an issue. On
other points, however, they take a very clear stand. Thus, they accurately note
that although "we have strongly argued in favor of attempting to identify and
cure genetic diseases, we have consistently urged that this only be done with the
informed consent of individual patients, and with informed public discussion of
the myriad issues and interests involved" (p. 270). Some readers may be disappointed by the evident preoccupation with what might be termed procedural
values, but the choice may also make the book a more useful source for policymakers.
My only complaint is that the book came out too soon to wrestle with what
is likely to be the biggest (at least in terms of dollars spent) genetic undertaking
of our lifetime: the decision whether to commit as much as three billion dollars
to sequencing (mapping) the human genome. The human genome project is intended to determine the identity, position, and function of the more than
100,000 genes in the human body. The map could thus significantly advance
our understanding of how specific gene defects produce diseases such as cancer.
There are a growing number of signs that the project will go forward.
Early this year, the National Research Council of the National Academy of Science issued a report recommending that the project go forward, and recommending that Congress approve an additional $200 million annually for fifteen
years to fund the project.' Congress has already appropriated more than $17
million to the National Institutes of Health (NIH) to formulate long-range plans
for the project.2
The only objections to the project until very recently have been raised by
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researchers who fear that such a huge project will divert funding from other
biomedical research. 3 Yet as the National Research Council report noted, "a
concerted effort to map and sequence the human genome would have profound
social significance." 4 For example, "diagnoses that trace diseases to our genes
can also convey stigma and set the scene for social prejudice." 5 The committee
also cautioned that gene maps might be used by companies or insurers to screen
out individuals who present occupational or insurance risks. The human
genome project thus raises far more significant issues than the proper balance
of power between large and small research projects.
Fortunately, a coalition of individuals and organizations representing civil
rights groups, organized labor, disability rights, women's organizations, public interest organizations, consumer and health organizations, and religious
groups has been formed to seek the establishment of a congressional board and
citizens committee to address the public policy implications of the project. 6
Surely we need to develop a public policy as sophisticated as our science on
these fundamental human matters. The Elias-Annas collaboration demonstrates that it is possible to link the two. I hope they will undertake a second
edition of this fine volume in order to give us the benefit of their thinking on
these latest developments.
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